ArticleHealth economics review2012
Estimating cost-effectiveness in public health: a summary of modelling and valuation methods.
Article in Health economics review, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Modelling health and economic impact of nutrition interventions: a systematic review.European journal of clinical nutrition · 2023Pooled it
- Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges.Health policy (Amsterdam, Netherlands) · 2017Pooled it
- Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues.BMC public health · 2013Pooled it
- Testing a Population-Based Outreach Intervention for Ovarian Cancer Survivors to Encourage their Close Relatives to Consider Genetic Counseling.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024Trial
- Cost effectiveness of a multi-component school-based physical activity intervention targeting adolescents: the 'Physical Activity 4 Everyone' cluster randomized trial.The international journal of behavioral nutrition and physical activity · 2016Trial
- Trial
- Cost-effectiveness analysis of insecticide ban aimed at preventing Parkinson's disease in Central California.The Science of the total environment · 2024Article
- A community health worker led approach to cardiovascular disease prevention in the UK-SPICES-Sussex (scaling-up packages of interventions for cardiovascular disease prevention in selected sites in Europe and Sub-saharan Africa): an implementation research project.Frontiers in health services · 2024Article
- Hospital Investment Decisions in Healthcare 4.0 Technologies: Scoping Review and Framework for Exploring Challenges, Trends, and Research Directions.Journal of medical Internet research · 2021Article
- Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling-an example from the cost-effectiveness analysis of the treatment of patients with predominantly negative symptoms of schizophrenia with cariprazine.Cost effectiveness and resource allocation : C/E · 2020Article
- An overview of systematic reviews of economic evaluations of pharmacy-based public health interventions: addressing methodological challenges.Systematic reviews · 2019Review
- PRIMEtime CE: a multistate life table model for estimating the cost-effectiveness of interventions affecting diet and physical activity.BMC health services research · 2019Article
- 2. How is the economic assessment of vaccines performed today?Journal of market access & health policy · 2017Review
- Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination.Journal of market access & health policy · 2017Review
- Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions.Population health metrics · 2016Article
- Comparing cost-effectiveness results for a vaccine across different countries worldwide: what can we learn?Advances in therapy · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is acknowledged that economic evaluation methods as they have been developed for Health Technology Assessment do not capture all the costs and benefits relevant to the assessment of public health interventions. This paper reviews methods that could be employed to measure and value the broader set of benefits generated by public health interventions. It is proposed that two key developments are required if this vision is to be achieved. First, there is a trend to modelling approaches that better capture the effects of public health interventions. This trend needs to continue, and economists need to consider a broader range of modelling techniques than are currently employed to assess public health interventions. The selection and implementation of alternative modelling techniques should be facilitated by the production of better data on the behavioural outcomes generated by public health interventions. Second, economists are currently exploring a number of valuation paradigms that hold the promise of more appropriate valuation of public health interventions outcomes. These include the capabilities approach and the subjective well-being approach, both of which offer the possibility of broader measures of value than the approaches currently employed by health economists. These developments should not, however, be made by economists alone. These questions, in particular what method should be used to value public health outcomes, require social value judgements that are beyond the capacity of economists. This choice will require consultation with policy makers, and perhaps even the general public. Such collaboration would have the benefit of ensuring that the methods developed are useful for decision makers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.